People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Salarius Pharmaceuticals, Inc. | — | Biotechnology | Series B | $34.6M | $57.8M | 2014 |
Stephen Barton Kraus at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Barton Kraus on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Barton Hutt | 1 | 14 |
| Christoph Westphal | 1 | 8 |
| David J. Arthur | 1 | 3 |
| MARK J. ROSENBLUM | 1 | 3 |
| Jonathan J. Lieber | 1 | 2 |
| Tess J. Burleson | 1 | 1 |
| William K. McVicar | 1 | 1 |
| Tess Burleson | 1 | 1 |
| Jonathan C. Lieber | 1 | 1 |
| Tess K. Burleson | 1 | 1 |
| Arnold C. Hanish | 1 | 1 |
| William J. McVicar | 1 | 1 |
| Bruce J. McCreedy | 1 | 1 |
| Paul C. Lammers | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.